Motoneuronal Sema3C is essential for setting stereotyped motor tract positioning in limb-derived chemotropic semaphorins.
The wiring of neuronal circuits requires complex mechanisms to guide axon subsets to their specific target with high precision. To overcome the limited number of guidance cues, modulation of axon responsiveness is crucial for specifying accurate trajectories. We report here a novel mechanism by which ligand/receptor co-expression in neurons modulates the integration of other guidance cues by the growth cone. Class 3 semaphorins (Sema3 semaphorins) are chemotropic guidance cues for various neuronal projections, among which are spinal motor axons navigating towards their peripheral target muscles. Intriguingly, Sema3 proteins are dynamically expressed, forming a code in motoneuron subpopulations, whereas their receptors, the neuropilins, are expressed in most of them. Targeted gain- and loss-of-function approaches in the chick neural tube were performed to enable selective manipulation of Sema3C expression in motoneurons. We show that motoneuronal Sema3C regulates the shared Sema3 neuropilin receptors Nrp1 and Nrp2 levels in opposite ways at the growth cone surface. This sets the respective responsiveness to exogenous Nrp1- and Nrp2-dependent Sema3A, Sema3F and Sema3C repellents. Moreover, in vivo analysis revealed a context where this modulation is essential. Motor axons innervating the forelimb muscles are exposed to combined expressions of semaphorins. We show first that the positioning of spinal nerves is highly stereotyped and second that it is compromised by alteration of motoneuronal Sema3C. Thus, the role of the motoneuronal Sema3 code could be to set population-specific axon sensitivity to limb-derived chemotropic Sema3 proteins, therefore specifying stereotyped motor nerve trajectories in their target field.
University of Lyon, UCBL1, CGphiMC, UMR CNRS 5534, 16 rue Raphael Dubois, 69622 Villeurbanne, France.
Isabelle
I
Sanyas
Muriel
M
Bozon
Frédéric
F
Moret
Valérie
V
Castellani
D000818:Animals; D030801:Animals, Genetically Modified; D019521:Body Patterning / Q000235:genetics*; D002478:Cells, Cultured; D002633:Chemotaxis / Q000235:genetics*; D002642:Chick Embryo; D005121:Extremities / Q000196:embryology* / Q000294:innervation*; D018507:Gene Expression Regulation, Developmental; D020439:Growth Cones / Q000378:metabolism / Q000502:physiology; D057809:HEK293 Cells; D006801:Humans; D009046:Motor Neurons / Q000378:metabolism / Q000502:physiology*; D055495:Neurogenesis / Q000235:genetics / Q000502:physiology; D039942:Neuropilin-1 / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D039943:Neuropilin-2 / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D039961:Semaphorins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D013131:Spine / Q000166:cytology / Q000196:embryology / Q000378:metabolism
D039943:Neuropilin-2; C543908:Sema3C protein, human; D039961:Semaphorins; D039942:Neuropilin-1